Feasibility of Sildenafil for the Prevention of Right Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation: The REVAD Trial
Canadian Journal of Cardiology · 2024
DOI: 10.1016/j.cjca.2023.11.017 ↗Kurz gefasst
Leserbrief in der Zeitschrift Canadian Journal of Cardiology, 2024. Verfasst von Nowell M Fine und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada. Electro…. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices, Ventricular Dysfunction, Left, Ventricular Dysfunction, Right. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Pfizer Canada.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada. Electronic address: nmfine@ucalgary.ca.
- Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.
- Division of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.
- Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
- Division of Cardiology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Förderung
- Pfizer Canada
Zitieren
APA
Fine, N. M., Litwin, O., Kent, W. D. T., Holloway, D. D., Roy, J., Miller, R. J. H., Chih, S., Davey, R. A., Isaac, D. L., Sharma, N., Lyons, K. J., & Howlett, J. G. (2024). Feasibility of Sildenafil for the Prevention of Right Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation: The REVAD Trial. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2023.11.017
Vancouver
Fine NM, Litwin O, Kent WDT, Holloway DD, Roy J, Miller RJH, et al. Feasibility of Sildenafil for the Prevention of Right Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation: The REVAD Trial. Canadian Journal of Cardiology. 2024. doi:10.1016/j.cjca.2023.11.017
BibTeX
@article{Fine2024,
author = {Fine, Nowell M and Litwin, Owen and Kent, William D T and Holloway, Daniel D and Roy, Jill and Miller, Robert J H and Chih, Sharon and Davey, Ryan A and Isaac, Debra L and Sharma, Nakul and Lyons, Kristin J and Howlett, Jonathan G},
title = {Feasibility of Sildenafil for the Prevention of Right Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation: The REVAD Trial},
journal = {Canadian Journal of Cardiology},
year = {2024},
doi = {10.1016/j.cjca.2023.11.017}
}
EUVIMED